Guiding Opinions Issued to Promote Healthy Development of Pharmaceutical Industry

The General Office of the State Council issued the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” which aims to promote the sustainable and healthy development of the pharmaceutical industry in China.

The Opinions specify seven key tasks to achieve this goal. The first is to strengthen technological innovation and enhance the core competitiveness. The second is to speed up quality upgrade and promote green and safe development. The third is to optimize the industrial structure and improve intensive development. The fourth is to develop modern logistics and build a pharmaceutical credit system. The fifth is to keep close pace with health care reforms and create a favorable market environment. The sixth is to deepen international cooperation and expand the space for international development. The seventh is to nurture emerging business forms and promote intellectual industrial development.

The Opinions require that it is imperative to strengthen fiscal and financial support, perfect the government procurement mechanism, deepen the reform of evaluation and approval, strengthen coordinated industrial supervision, support the promotion of innovative products, and accelerate the building of talent teams. The National Development and Reform Commission shall strengthen planning and co-ordination, clarify the specific schedule for the implementation of various policy measures and, in concert with the relevant departments, strengthen policy guidance and supervision and inspection, so as to promote sustainable and healthy development of the pharmaceutical industry.

Read the original in Chinese